{"schema_version":"secwatch.filing_event.v1","accession":"0001437402-25-000021","form_type":"8-K","ticker":"ARDX","cik":"0001437402","company_name":"ARDELYX, INC.","filed_at":"2025-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.412609+00:00","generated_at":"2026-05-16T12:54:28.023320+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Ardelyx CLO and CMO resign effective Dec 31; interim CMO appointed","bullets":["Elizabeth Grammer resigns as Chief Legal and Administrative Officer effective Dec 31, 2025; will serve as General Counsel then Senior Advisor for 24 months.","Edward Conner resigns as CMO effective Dec 31, 2025 for personal reasons; Dr. Laura Williams appointed interim CMO.","Grammer transition agreement: retains base salary, target bonus 45% for 2025, no ongoing bonus as advisor; equity continues vesting.","Laura Williams, former CMO and current Chief Patient Officer, serves as interim CMO until permanent hire."],"urls":{"canonical":"https://secwatch.observer/filing/0001437402-25-000021","json":"https://secwatch.observer/filing/0001437402-25-000021.json","markdown":"https://secwatch.observer/filing/0001437402-25-000021.md","text":"https://secwatch.observer/filing/0001437402-25-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1437402/000143740225000021/0001437402-25-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1437402/000143740225000021/ardx-20251217.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:54:28.023320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}